|
|
||||||||
Ann Thorac Surg 2004;78:404-409
© 2004 The Society of Thoracic Surgeons
ski, MD, PhDa*
aw Ku
d
a
, MD, PhDa
a Department of Thoracic Surgery, Pulmonary Hospital, Zakopane, Poland
b Department of Interventional Pulmonology, Jagiellonian University, Kraków, Poland
Accepted for publication February 6, 2004.
* Address reprint requests to Dr Zieli
ski, ul. G
adkie 1, 34-500 Zakopane, Poland
e-mail: marcinz{at}mp.pl
| Abstract |
|---|
|
|
|---|
METHODS: One-hundred "maximal" transcervical-subxiphoid-videothoracoscopic thymectomies were performed for nonthymomatous myasthenia gravis during a recent 32-month period (from September 1, 2000 to May 8, 2003). Patient characteristics, complications, pathologic findings, and the results of follow-up were analyzed.
RESULTS: The study group included 83 women and 17 men. The mean age was 29.8 years (range, 1069 years). The mean preoperative duration of myasthenia was 2.73 years (range, 3 months to 17 years). The preoperative Osserman score was IIII, 27 patients were taking steroids preoperatively. Eleven operations were performed by two teams working simultaneously and 89 operations were performed by one surgeon including four combined thymectomy-thyroid operations in patients with myasthenia and thyroid nodules. The mean operative time for two-team approach thymectomies was 159.09 minutes (range, 140170 minutes) and the mean operative time for the thymectomy performed by one surgeon was 199.41 minutes (range, 150270 minutes) (p = 0.0004). There was a 15.0% (15 out of 100) postoperative morbidity and no mortality. Foci of ectopic thymic tissue were found in 71.0% of the patients and were most prevalent in the perithymic fat (37.0%) and in the aorta-pulmonary window (33.0%). The mean weight of the specimen was 78.4 g (range, 14.5253.0 g). In 48 patients followed-up for 12 months, the improvement rate was 83.3%, the no improvement rate was 14.6%, and 1 patient died during the follow-up period. Complete remission rates were 18.8% and 32.0% after 1 and 2 years of follow-up, respectively.
CONCLUSIONS: We conclude that the "maximal" transcervical-subxiphoid-videothoracoscopic thymectomy is a safe operative technique, avoiding a sternotomy, performed partly in an open fashion with the extensiveness comparable with the transsternal extended and "maximal" thymectomies. The two-team approach helps to reduce the operative time. However, because of the limited time of follow-up it is too early for the final assessment of the long-term results of this method in the treatment of myasthenia gravis.
| Introduction |
|---|
|
|
|---|
lowski in 1912 [1] and afterwards by Masaoka and associates and Jaretzki and associates that the gross and microscopic foci of thymic tissue are widely distributed in cervical and mediastinal fat outside the thymic gland and can be found in 39.5%98.0% of patients undergoing thymectomy [24]. There were 784 thymectomies in myasthenia gravis performed in the period 19672003 at the Department of Thoracic Surgery in The Pulmonary Hospital in Zakopane. All operations performed during 19671997 were basic thymectomies executed through the superior partial longitudinal sternotomy. Afterwards 74 extended transsternal thymectomies were performed for nonthymomatous myasthenia gravis in the period from January 1, 1998 to June 30, 2000. This technique includes a wide opening of both pleural cavities and the complete exenteration of the fatty tissue of the lower-anterior part of the neck and anterior and middle mediastinum from the level of the lower poles of the thyroid gland to the diaphragm; laterally both phrenic nerves are the margins of resection. In 56.9% of the patients, ectopic foci of thymic tissue in the fat of the neck or mediastinum were found [5]. Although the extended thymectomy is a major procedure, there were few postoperative complications similar to those noted after a basic thymectomy [5]. The total sternotomy is an obvious drawback of that procedure, therefore since July 2000 we have started to use a less invasive technique described by Novellino and associates [6] and subsequently we have developed an original technique called a "maximal" transcervical-subxiphoid-videothoracoscopic thymectomy [7] which we describe in this report. | Material and methods |
|---|
|
|
|---|
The operative technique of this procedure is as follows: a patient is positioned supine on the operating table with a roll placed beneath the thoracic spine to elevate the chest and to hyperextend the patient's neck. Under general anesthesia an endobronchial tube is inserted to conduct selective lung ventilation during the latter part of the procedure. The skin is prepared from the chin to the umbilicus and bilaterally past the posterior axillary line. To shorten the operative time, the procedure may be performed by two teamsone called the "cervical team" working from above and the other called "the subxiphoid team" working from below the sternum. Alternatively, the whole operation is performed by one surgeon.
The cervical part of the operation: a transverse 58 cm incision is made in the neck above the sternal notch. The platysma and superficial cervical fascia are divided and the anterior jugular veins are divided and suture-ligated. The strap muscles are split along their median raphe and retracted laterally. The whole thyroid gland is visualized and all the adipose tissue is removed downward from the level of the upper poles of the thyroid gland. The parathyroid glands and both laryngeal recurrent nerves are visualized and carefully preserved. The fatty tissue containing the superior poles of the thymus is separated from the lower poles of the thyroid gland with one to four inferior thyroid veins ligated and divided. The thymus with the surrounding fat is then separated from the sternohyoid and sternothyroid muscles, the trachea, the internal surface of the sternum, the carotid arteries, the innominate artery, the aorta, and the right innominate vein. At this point a sternal retractor connected to the firm frame with a traction mechanism is inserted under the manubrium of the sternum to elevate it several centimeters to provide access to the anterior mediastinum. The inferior thyroid veins [14] and the thymic veins [14] are dissected, clipped, and divided close to the left innominate vein. The fatty tissue from the area called "the aorta-caval groove" is removed. The boundaries of this space are the division of the innominate artery and the aorta (medially), the trachea (posteriorly), the right innominate vein and the right mediastinal pleura (laterally), and the right main bronchus, azygos vein, and superior vena cava (inferiorly). The dissection proceeds caudally below the left innominate vein and the specimen is separated from the pericardium at a distance of several centimeters (Fig 1). The most difficult but very important part of this operation is the dissection of the adipose tissue from the aorta-pulmonary window. Further dissection of two other branches of the left innominate vein, namely the left internal thoracic vein and the accessory hemiazygos vein, is mandatory. These two veins are subsequently divided and their ends are secured with clips or suture-ligatures (preferably). The division of these veins provides much better access to the aorta-pulmonary window above the left innominate vein that is retracted toward the aorta. The next step is the visualization of the left phrenic nerve that runs very close to the left internal thoracic vein and the left vagus nerve that runs laterally to the left common carotid artery. With blunt dissection using a peanut sponge, the fatty tissue of the aorta-pulmonary window is dissected from these nerves, the aorta, and the left mediastinal pleura. At the bottom of the aorta-pulmonary window the left pulmonary artery is visualized. In difficult patient cases the dissection of the aorta-pulmonary window is completed at a later stage of the operation with a videothoracoscopic camera inserted inside the chest.
|
|
|
| Results |
|---|
|
|
|---|
There was a 15.0% postoperative morbidity and no mortality in the whole group. The intraoperative and postoperative complications are listed in Table 1. The complications included a small laceration of the vena cava in 1 patient which was repaired using vascular clips without sternotomy. Two patients required revision (without sternotomy) for postoperative bleeding (one from the left internal thoracic vein and the other from the anterior jugular vein). One pleural hematoma necessitated needle aspiration and in the other patient unilateral chest redrainage and a subsequent videothoracoscopy for removal of the residual blood clots on the eleventh day after the first procedure was necessary; there was one transient paresis of the left laryngeal recurrent nerve which subsided after 3 months. Five patients (5%) needed ventilator support for respiratory insufficiency for 35 days. In 1 patient a subarachnoid hemorrhage occurred on the fourth postoperative day; the patient was transferred to the neurosurgical department and operated on successfully. Pneumonia without respiratory insufficiency developed in 1 patient and 2 patients had minor problems with the subxiphoid wound. There were no conversions to sternotomy and no need for tracheostomy in any patient. In the pathologic studies, ectopic foci of the thymic tissue containing the Hassall's corpuscles were found in 48 patients and highly probable foci but without Hassall's corpuscles were found in 28 patients. Overall, proven or highly suspected foci of thymic tissue were discovered in 71 patients (in some patients, both proven and suspected foci were found). In 13 patients ectopic foci were found in two areas, in 7 patients in three areas, and in 1 patient in four areas. Table 2 presents the incidence of the proven and suspected ectopic foci by localization. The incidence of foci was highest in the perithymic region (37.0%) and in the aorta-pulmonary window (33.0%). The mean weight of the specimen was 78.4 g (range, 14.5253.0 g) which is comparable with the mean weight of the specimen in 58 patients operated on at our department by the transsternal extended thymectomy in the period 19981999 (mean weight, 73.7 g; range, 21.5248.6 g). There were 48 patients after transcervical-subxiphoid-videothoracoscopic "maximal" thymectomy followed up for more than 12 months, therefore the results of the follow-up of this group can only be analyzed. No patients were lost from follow-up and all patients responded to the questionnaires. Forty out of 48 patients (83.3%) improved, 7 out of 48 patients (14.6%) showed no improvement, and 1 patient died 4 months after the operation from a hemorrhage of a gastric ulcer; the patient was taking high doses of steroids preoperatively and postoperatively. In none of the patients was deterioration of myasthenia reported. The 1-year complete remission rate (no myasthenic symptoms and no drugs needed) was 18.8% (9 out of 48) and the 2-year remission rate was 32% (8 out of 25). The relation between the Osserman score and complete remission rate in patients in whom the results of 1 and 2 years of follow-up are available is presented in Table 3.
|
|
|
| Comment |
|---|
|
|
|---|
Despite the possibility of also using this technique in patients of thymoma, we continue to operate on such patients with the transsternal technique, similar to the one described by Bulkley and associates, to minimize the danger of violating the tumor's capsule with dissemination of the neoplasm [18]. We operated on 5 patients with the technique reported by Novellino and associates [6]. Unfortunately, the intrathoracic part of this operation is a pure videothoracoscopic procedure which is very tedious and very difficult when performing en block dissection of the whole specimen. For these reasons, we started to operate on myasthenic patients using our own technique which seems to be much simpler. Our technique is similar to the one described by Takeo and associates [13], however there are several differences between both methods. The procedure performed by Takao and associates is executed mainly thoracoscopically through three ports on each side and with the use of a harmonic scalpel. Our method is performed mainly in an open fashion with only one port on each side and with instruments used for open surgery. Additionally, a two-team approach proposed by our method helps to reduce the time of the operation. The extensiveness of the procedure of Takeo and associates was not described in detail. The "maximal" transcervical-subxiphoid-videothoracoscopic thymectomy is a relatively safe procedure with no mortality and a 15% morbidity rate plus only 5% of the patients needed the support of a ventilator. The postoperative respiratory insufficiency rate in patients operated on in our department using the transsternal extended thymectomy was 5.2% [5]. Although there were only a few complications related to the sternotomy wound in previous experiences in our department, with only two sternal dehiscences in 680 thymectomies (including thymomas and rethymectomies) [19], there is always the risk of such complications. Currently, we are comparing prospectively the pain intensity and the postoperative spirometric changes in patients operated on with the extended transsternal thymectomy for myasthenia with thymomas and patients operated on with the presented method for nonthymomatous myasthenia. The mean weights of the specimen in the "maximal" transcervical-subxiphoid-videothoracoscopic thymectomy and the transsternal extended thymectomy groups operated on at our department in 1998/1999 are comparable (78.4 g vs 73.7 g, respectively) which supports our presumption that the extensiveness of both methods is similar [5]. At present, it is possible to report the results of 1 and 2 years of follow-up only in a small part of the whole group (48 out of 100 and 19 out of 100 patients, respectively). The complete remission rates after 1 and 2 years of follow-up are 18.8% and 32.0%, respectively. The results are acceptable, however it is too early to asses the long-term effectiveness of this procedure. There was a trend toward better results regarding the complete remission rates in the lower Osserman stages (I, IIA, and II B) contrary to no remissions in stage III (Table 3). However, because of the small numbers of patients in this subgroups, a statistical analysis is not possible.
We conclude that the "maximal" transcervical-subxiphoid-videothoracoscopic thymectomy is a relatively safe technique, avoiding the use of the sternotomy, performed partly in an open fashion with the extensiveness comparable with the extended transsternal and transcervical-transsternal thymectomies. The two-team approach helps to reduce the operative time. The early results of the follow-up for part of the whole group are acceptable, but the final evaluation of this method in the treatment of myasthenia gravis will be possible in the future.
| References |
|---|
|
|
|---|
owski R. Ueber die Halsfisteln und Cysten. Arch Klin Chirurgie 1912;98:151-201.
ski M, K
z
za
J, Szlubowski A, Soja J. Comparison of late results of basic transsternal and extended transsternal thymectomies in the treatment of myasthenia gravis. Ann Thorac Surg (Accepted for publication)
ski M. Technique of transcervical-subxiphoid-VATS "maximal" thymectomy in treatment of myasthenia gravis. Przegl
d Lekarski 2000;57(Suppl 5):64-65.
ski M, Ku
d
a
J, Staniec B, Harazda M, Nabia
ek T, Pankowski J, et al. Safety of preoperative use of steroids for transsternal thymectomy in myasthenia gravis. Book of abstracts. 2nd EACTS/ESTS Joint Meeting, Vienna, Austria, 1215 October 2003This article has been cited by other articles:
![]() |
F. Dexter, E. U. Dexter, D. Masursky, and N. A. Nussmeier Systematic Review of General Thoracic Surgery Articles to Identify Predictors of Operating Room Case Durations Anesth. Analg., April 1, 2008; 106(4): 1232 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Augustin, T. Schmid, M. Sieb, P. Lucciarini, and J. Bodner Video-Assisted Thoracoscopic Surgery versus Robotic-Assisted Thoracoscopic Surgery Thymectomy Ann. Thorac. Surg., February 1, 2008; 85(2): S768 - S771. [Full Text] [PDF] |
||||
![]() |
F. Cakar, P. Werner, F. Augustin, T. Schmid, A. Wolf-Magele, M. Sieb, and J. Bodner A comparison of outcomes after robotic open extended thymectomy for myasthenia gravis Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 501 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tomulescu, V. Ion, A. Kosa, O. Sgarbura, and I. Popescu Thoracoscopic thymectomy mid-term results. Ann. Thorac. Surg., September 1, 2006; 82(3): 1003 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Rubin Invited commentary. Ann. Thorac. Surg., September 1, 2006; 82(3): 1007 - 1008. [Full Text] [PDF] |
||||
![]() |
F. Rea, G. Marulli, L. Bortolotti, P. Feltracco, A. Zuin, and F. Sartori Experience With the "Da Vinci" Robotic System for Thymectomy in Patients With Myasthenia Gravis: Report of 33 Cases Ann. Thorac. Surg., February 1, 2006; 81(2): 455 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Manlulu, T. W. Lee, I. Wan, C. Y. Law, C. Chang, J. C. Garzon, and A. Yim Video-Assisted Thoracic Surgery Thymectomy for Nonthymomatous Myasthenia Gravis Chest, November 1, 2005; 128(5): 3454 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watanabe, R. Yozu, and K. Kobayashi Preliminary experience with minimally invasive video-assisted surgery for thymic diseases, including myasthenia gravis, through a horizontal ministernotomy J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 912 - 913. [Full Text] [PDF] |
||||
![]() |
M. de Kraker, J. Kluin, N. Renken, A. P.W.M. Maat, and A. J.J.C. Bogers CT and myasthenia gravis: correlation between mediastinal imaging and histopathological findings Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 267 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zielinski, J. Kuzdzal, and T. Nabialek Transcervical-subxiphoid-VATS "maximal" thymectomy for myasthenia gravis MMCTS, April 25, 2005; 2005(0425): 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kuzdzal, M. Zielinski, B. Papla, A. Szlubowski, L. Hauer, T. Nabialek, W. Sosnicki, and J. Pankowski Transcervical extended mediastinal lymphadenectomy--the new operative technique and early results in lung cancer staging Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 384 - 390. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |